Results 221 to 230 of about 10,950 (303)

Morphine Tolerance Gated through EZH2‐Mediated Suppression of Trpc5 in Spinal GABAergic Interneurons in Male Mice

open access: yesAdvanced Science, Volume 13, Issue 1, 5 January 2026.
Chronic morphine suppresses Trpc5 in spinal GABAergic interneurons via EZH2‐mediated histone modification, reducing Ca2+ influx and GABA release. TRPC5 activation enhances morphine analgesia, while EZH2 inhibition restores efficacy and reverses tolerance.
Li Wan   +9 more
wiley   +1 more source

Aptamer Engineering: Strategies for Discovering Functional Nucleic Acids for Next‐Generation Diagnostics and Biosensing

open access: yesAdvanced Science, Volume 13, Issue 2, 9 January 2026.
The advent of aptamers has highlighted their potential as alternatives to antibodies, overcoming limitations of structural instability and production cost. However, conventional approaches such as SELEX remain slow and labor‐intensive. This review examines recent advances in aptamer engineering, emphasizing in vitro and AI‐driven in silico strategies ...
John V. L. Nguyen   +5 more
wiley   +1 more source

The structure of the designed 1,2,3-triazole-tethered derivatives of morphine.

open access: green
Faeze Nourmandipour (21553208)   +6 more
openalex   +1 more source

Artificial Super‐Receptor Interface Mimic and Exceed Protein Functionality

open access: yesAggregate, Volume 7, Issue 1, January 2026.
Protein‐mimicking artificial super‐receptor was developed from protein‐similar pure organic groups to super‐performed artificial interface, and achieved revolutionary broad‐spectrum specificity for amphetamine drugs mimicking to protein functionality; and super‐performance beyond nature (64,580× sensitivity of human DAT protein).
Wei Xu   +16 more
wiley   +1 more source

The Effects of Bone‐Remodeling Therapy on Survival, Pain, and Skeletal Related Events in the Setting of Renal Cell Carcinoma With Bone Metastases: A Multicenter Investigation From a Large Global Health Research Network (TriNetX)

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
In this retrospective population study containing 139,859 patients, subjects receiving RANK‐ligand inhibitors had improved survival and decreased rates of skeletal‐related events relative to the overall cohort of patients with metastatic bone lesions.
Brian H. Im   +9 more
wiley   +1 more source

Uncovering New Antimelanoma Strategies: Experimental Insights into Semisynthetic Pentacyclic Triterpenoids. [PDF]

open access: yesLife (Basel)
Ungureanu Similie D   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy